5,7-dihydroxytryptamine has been researched along with Disease Models, Animal in 32 studies
*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.13) | 18.7374 |
| 1990's | 2 (6.25) | 18.2507 |
| 2000's | 11 (34.38) | 29.6817 |
| 2010's | 17 (53.13) | 24.3611 |
| 2020's | 1 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, JD; Irvine, KA; Liang, DY; Sahbaie, P; Shi, X | 1 |
| Cao, L; Liu, C; Lu, J; Lu, X; Meng, D; Wang, G; Xu, T; Yun, J; Zhang, Z; Zhao, C | 1 |
| Hu, LF; Liu, CF; Liu, JY; Lv, DJ; Mao, CJ; Wang, CT; Wang, F; Xia, KL; Xu, GY; Yang, YP; Zhang, CY; Zhang, XQ | 1 |
| Carvalho, MC; Padovan, CM; Pereira, AC | 1 |
| Carr, FB; Géranton, SM; Hunt, SP | 1 |
| Furukawa, S; Furukawa, Y; Ishikawa, K; Ishikawa, T; Iwanaga, Y; Nakano, M; Okuyama, S; Suenaga, H; Yamagata, H; Yasuda, S; Yoshida, M | 1 |
| Cook, A; Forster, GL; Mears, M; Renner, KJ; Scholl, JL; Tu, W; Watt, MJ | 1 |
| Belzung, C; Bodard, S; Chalon, S; Coubard, S; Yalcin, I | 1 |
| Amado, D; Cavalheiro, EA; de A Carvalho, R; de Castro-Neto, EF; Lima, E; Naffah-Mazzacoratti, Mda G; Scorza, FA; Trindade-Filho, EM | 1 |
| Brundin, P; Cenci, MA; Lane, EL | 1 |
| Adams, W; Ayton, S; van den Buuse, M | 1 |
| Brandão, ML; Diwan, M; Fletcher, PJ; Gonzalez-Lima, F; Hamani, C; Lozano, AM; Macedo, CE; Nobrega, JN; Raymond, R; Shumake, J | 1 |
| Biezonski, DK; Meyer, JS | 1 |
| Cragg, JJ; Ramer, MS; Scott, AL | 1 |
| Kompagne, H; Kuki, Z; Lévay, G; Markó, B; Nagy, KM; Sziray, N | 1 |
| Bioulac, B; De Deurwaerdère, P; Gross, C; Navailles, S | 1 |
| Kung, LH; Scrogin, KE | 1 |
| Hirota, K; Kudo, M; Kudo, T; Kushikata, T | 1 |
| Frazer, A; Furmaga, H; Shah, A | 1 |
| Covolan, L; Dubiela, FP; Hamani, C; Hipólide, DC; Macedo, CE; Machado, DC; Martins, U; Nobrega, JN; Suchecki, D; Tescarollo, F | 1 |
| Dilleen, R; Economidou, D; Everitt, BJ; Pelloux, Y; Theobald, D | 1 |
| Bridgman, A; Creed, MC; Fletcher, PJ; Hamani, C; Nobrega, JN | 1 |
| Andrade, TG; Bueno, C; Pobbe, RL; Sena, LM; Viana, MB; Zangrossi, H | 1 |
| Copolov, DL; Kusljic, S; van den Buuse, M | 1 |
| Andrade, TG; Graeff, FG; Macedo, CE; Zangrossi, H | 1 |
| Kim, JE; Liu, BP; Park, JH; Strittmatter, SM | 1 |
| Browning, RA; Clough, RW; Jobe, PC; Merrill, MA | 1 |
| Berniker, AV; Cafaro, C; Gao, HG; Kelly, ML; Kereshi, B; Kinney, HC; Li, A; Nattie, EE; Niblock, MM; Penatti, EM | 1 |
| Kilts, CD; Lewis, MH; Mailman, RB | 1 |
| Brus, R; Fuller, RW; Kalbfleisch, JH; Kostrzewa, RM; Perry, KW | 1 |
| Gonzales, W; Pluchino, R; Pranzatelli, MR; Simmens, S; Tailor, PT | 1 |
| Bolser, DC; Golder, FJ; Reier, PJ | 1 |
1 review(s) available for 5,7-dihydroxytryptamine and Disease Models, Animal
| Article | Year |
|---|---|
Animal models related to developmental disorders: theoretical and pharmacological analyses.
Topics: 5,7-Dihydroxytryptamine; Amphetamine; Animals; Attention Deficit Disorder with Hyperactivity; Brain; Depressive Disorder; Developmental Disabilities; Disease Models, Animal; Haemophilus influenzae; Haplorhini; Humans; Hydroxydopamines; Lead; Meningitis, Haemophilus; Mice; Neurotransmitter Agents; Rats; Receptors, Dopamine; Schizophrenia; Sodium Glutamate | 1981 |
31 other study(ies) available for 5,7-dihydroxytryptamine and Disease Models, Animal
| Article | Year |
|---|---|
Mild Traumatic Brain Injury Causes Nociceptive Sensitization through Spinal Chemokine Upregulation.
Topics: 5,7-Dihydroxytryptamine; Animals; Benzamides; Brain Injuries, Traumatic; Chemokine CXCL1; Chemokine CXCL2; Cyclobutanes; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fenclonine; Immunohistochemistry; Male; Mice; Ondansetron; Real-Time Polymerase Chain Reaction; Receptors, Interleukin-8B; Receptors, Serotonin, 5-HT1; Receptors, Serotonin, 5-HT3 | 2019 |
Elimination of Serotonergic Neurons by Stereotaxic Injection of 5,7-Dihydroxytryptamine in the Dorsal Raphe Nuclei of Mice.
Topics: 5,7-Dihydroxytryptamine; Animals; Behavior, Animal; Disease Models, Animal; Dorsal Raphe Nucleus; Male; Mice, Inbred C57BL; Serotonergic Neurons; Stereotaxic Techniques | 2020 |
Attenuation of hyperalgesia responses via the modulation of 5-hydroxytryptamine signalings in the rostral ventromedial medulla and spinal cord in a 6-hydroxydopamine-induced rat model of Parkinson's disease.
Topics: 5,7-Dihydroxytryptamine; Animals; Disease Models, Animal; gamma-Aminobutyric Acid; Hyperalgesia; Indoles; Male; Medulla Oblongata; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Signal Transduction; Spinal Cord; Sympatholytics; Tyrosine 3-Monooxygenase | 2017 |
Both serotonergic and noradrenergic systems modulate the development of tolerance to chronic stress in rats with lesions of the serotonergic neurons of the median raphe nucleus.
Topics: 5,7-Dihydroxytryptamine; Analysis of Variance; Animals; Desipramine; Disease Models, Animal; Dorsal Raphe Nucleus; Drug Tolerance; Fluoxetine; Hippocampus; Male; Maze Learning; Neurotransmitter Uptake Inhibitors; Norepinephrine; Rats; Rats, Wistar; Serotonergic Neurons; Serotonin; Serotonin Agents; Stress, Psychological | 2019 |
Descending controls modulate inflammatory joint pain and regulate CXC chemokine and iNOS expression in the dorsal horn.
Topics: 5,7-Dihydroxytryptamine; Animals; Arthritis; Chemokines, CXC; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulation; Hyperalgesia; Male; Medulla Oblongata; Neural Pathways; Nitric Oxide Synthase Type II; Opioid Peptides; Pain; Pain Threshold; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Ribosome Inactivating Proteins, Type 1; Saporins; Serotonin Agents; Spinal Cord | 2014 |
Imipramine ameliorates pain-related negative emotion via induction of brain-derived neurotrophic factor.
Topics: 5,7-Dihydroxytryptamine; Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Chronic Pain; Constriction, Pathologic; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Emotions; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Gyrus Cinguli; Imipramine; Male; Phosphorylation; Rats, Sprague-Dawley; Reaction Time; RNA, Messenger; Serotonin; Spinal Cord | 2014 |
Serotonin in the ventral hippocampus modulates anxiety-like behavior during amphetamine withdrawal.
Topics: 5,7-Dihydroxytryptamine; Amphetamine; Amphetamine-Related Disorders; Animals; Anxiety; Central Nervous System Stimulants; Disease Models, Animal; Hippocampus; Male; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Substance Withdrawal Syndrome | 2014 |
Effects of 5,7-dihydroxytryptamine lesion of the dorsal raphe nucleus on the antidepressant-like action of tramadol in the unpredictable chronic mild stress in mice.
Topics: 5,7-Dihydroxytryptamine; Animals; Antidepressive Agents; Behavior, Animal; Brain; Chromatography, High Pressure Liquid; Depression; Disease Models, Animal; Male; Mice; Mice, Inbred BALB C; Raphe Nuclei; Serotonin; Stress, Psychological; Tramadol | 2008 |
Serotonin depletion effects on the pilocarpine model of epilepsy.
Topics: 5,7-Dihydroxytryptamine; Acute Disease; Animals; Behavior, Animal; Chronic Disease; Disease Models, Animal; Disease Susceptibility; Electroencephalography; Epilepsies, Partial; Hippocampus; Male; Muscarinic Agonists; Pilocarpine; Raphe Nuclei; Rats; Rats, Wistar; Recurrence; Serotonin; Serotonin Antagonists; Status Epilepticus | 2008 |
Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease.
Topics: 5,7-Dihydroxytryptamine; Adrenergic Agents; Amphetamine; Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Dopamine Uptake Inhibitors; Dyskinesias; Embryo, Mammalian; Female; Levodopa; Mesencephalon; Oxidopamine; Parkinson Disease; Pregnancy; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Transplants; Tyrosine 3-Monooxygenase | 2009 |
Serotonergic lesions of the dorsal hippocampus differentially modulate locomotor hyperactivity induced by drugs of abuse in rats: implications for schizophrenia.
Topics: 5,7-Dihydroxytryptamine; Amphetamines; Animals; Cocaine; Disease Models, Animal; Dose-Response Relationship, Drug; Hippocampus; Hyperkinesis; Ketamine; Male; Phencyclidine; Rats; Rats, Sprague-Dawley; Schizophrenia; Serotonin | 2009 |
Antidepressant-like effects of medial prefrontal cortex deep brain stimulation in rats.
Topics: 5,7-Dihydroxytryptamine; Adrenergic Agents; Analysis of Variance; Animals; Benzylamines; Catheter Ablation; Deep Brain Stimulation; Depression; Disease Models, Animal; Excitatory Amino Acid Agonists; Exploratory Behavior; Feeding Behavior; Food Preferences; GABA Agonists; Helplessness, Learned; Ibotenic Acid; Male; Microdialysis; Muscimol; Prefrontal Cortex; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Swimming | 2010 |
Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
Topics: 5,7-Dihydroxytryptamine; Animals; Area Under Curve; Benzylamines; Brain; Central Nervous System Stimulants; Disease Models, Animal; Female; Gene Expression; Hallucinogens; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Neurotransmitter Uptake Inhibitors; Pregnancy; Protein Binding; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Plasma Membrane Transport Proteins; Synaptosomes; Time Factors; Vesicular Monoamine Transport Proteins | 2010 |
Depletion of spinal 5-HT accelerates mechanosensory recovery in the deafferented rat spinal cord.
Topics: 5,7-Dihydroxytryptamine; Animals; Brain; Brain-Derived Neurotrophic Factor; Calcitonin Gene-Related Peptide; Disease Models, Animal; Hyperalgesia; Hypesthesia; Lectins; Male; Microglia; Neuropeptide Y; Pain Threshold; Peripheral Nervous System Diseases; Physical Stimulation; Rats; Rats, Sprague-Dawley; Recovery of Function; Rhizotomy; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Spinal Cord; Spinal Nerve Roots; Tyrosine 3-Monooxygenase; Up-Regulation; Vesicular Glutamate Transport Protein 1 | 2010 |
Effects of single and simultaneous lesions of serotonergic and noradrenergic pathways on open-space and bright-space anxiety-like behavior in two animal models.
Topics: 5,7-Dihydroxytryptamine; Adaptation, Physiological; Adrenergic Agents; Adrenergic Uptake Inhibitors; Animals; Anxiety; Benzylamines; Chromatography, High Pressure Liquid; Desipramine; Disease Models, Animal; Exploratory Behavior; Fluoxetine; Injections, Intraventricular; Male; Maze Learning; Motor Activity; Norepinephrine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Spatial Behavior | 2010 |
Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease.
Topics: 5,7-Dihydroxytryptamine; Animals; Antiparkinson Agents; Brain; Citalopram; Cobra Neurotoxin Proteins; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Extracellular Fluid; Levodopa; Male; Microdialysis; Oxidopamine; Parkinsonian Disorders; Presynaptic Terminals; Raphe Nuclei; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Sympatholytics; Synaptic Transmission | 2010 |
Serotonin nerve terminals in the dorsomedial medulla facilitate sympathetic and ventilatory responses to hemorrhage and peripheral chemoreflex activation.
Topics: 5,7-Dihydroxytryptamine; Adaptation, Physiological; Animals; Baroreflex; Blood Pressure; Chemoreceptor Cells; Disease Models, Animal; Heart Rate; Hemorrhage; Hypotension; Hypovolemia; Injections; Kidney; Male; Medulla Oblongata; Neural Pathways; Potassium Cyanide; Presynaptic Terminals; Pulmonary Ventilation; Rats; Rats, Sprague-Dawley; Recovery of Function; Serotonergic Neurons; Serotonin Agents; Sympathetic Nervous System; Time Factors | 2011 |
Antinociceptive effects of neurotropin in a rat model of central neuropathic pain: DSP-4 induced noradrenergic lesion.
Topics: 5,7-Dihydroxytryptamine; Adrenergic Agents; Analgesics; Animals; Area Under Curve; Benzylamines; Disease Models, Animal; Electrochemistry; Locus Coeruleus; Male; Neuralgia; Norepinephrine; Pain Measurement; Polysaccharides; Rats; Rats, Sprague-Dawley; Reaction Time; Serotonin Agents | 2011 |
Serotonergic and noradrenergic pathways are required for the anxiolytic-like and antidepressant-like behavioral effects of repeated vagal nerve stimulation in rats.
Topics: 5,7-Dihydroxytryptamine; Adrenergic Agents; Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Anxiety; Autoradiography; Brain; Desipramine; Disease Models, Animal; Drug Delivery Systems; Exploratory Behavior; Feeding Behavior; Imipramine; Immobility Response, Tonic; Male; Neural Pathways; Norepinephrine; Oxidopamine; Protein Binding; Rats; Rats, Sprague-Dawley; Reaction Time; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Antagonists; Sertraline; Swimming; Time Factors; Tritium; Vagus Nerve Stimulation | 2011 |
Deep brain stimulation reverses anhedonic-like behavior in a chronic model of depression: role of serotonin and brain derived neurotrophic factor.
Topics: 5,7-Dihydroxytryptamine; Animals; Brain-Derived Neurotrophic Factor; Deep Brain Stimulation; Depression; Disease Models, Animal; Electrodes, Implanted; Gene Expression Regulation; Male; Prefrontal Cortex; Rats; Rats, Wistar; Serotonin; Serotonin Agents; Sucrose; Time Factors; Water Deprivation | 2012 |
Reduced forebrain serotonin transmission is causally involved in the development of compulsive cocaine seeking in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5,7-Dihydroxytryptamine; Animals; Behavior, Addictive; Cocaine; Conditioning, Operant; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Hydroxyindoleacetic Acid; Male; Prosencephalon; Punishment; Rats; Reinforcement Schedule; Reinforcement, Psychology; Self Administration; Serotonin; Serotonin Agents; Synaptic Transmission; Time Factors | 2012 |
Contribution of decreased serotonin release to the antidyskinetic effects of deep brain stimulation in a rodent model of tardive dyskinesia: comparison of the subthalamic and entopeduncular nuclei.
Topics: 5,7-Dihydroxytryptamine; Amphetamines; Analysis of Variance; Animals; Antipsychotic Agents; Autoradiography; Benzylamines; Carbon Isotopes; Chromatography, High Pressure Liquid; Deep Brain Stimulation; Disease Models, Animal; Electrochemical Techniques; Entopeduncular Nucleus; Exploratory Behavior; Fluoxetine; Haloperidol; Hydroxyindoleacetic Acid; Male; Mastication; Microdialysis; Movement Disorders; Protein Binding; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Receptor Agonists; Subthalamic Nucleus | 2012 |
The dorsal raphe nucleus exerts opposed control on generalized anxiety and panic-related defensive responses in rats.
Topics: 5,7-Dihydroxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anxiety; Avoidance Learning; Carbolines; Disease Models, Animal; Escape Reaction; GABA Agonists; GABA Antagonists; Male; Muscimol; Neural Pathways; Panic Disorder; Raphe Nuclei; Rats; Rats, Wistar; Serotonin; Serotonin Receptor Agonists | 2003 |
Differential role of serotonergic projections arising from the dorsal and median raphe nuclei in locomotor hyperactivity and prepulse inhibition.
Topics: 5,7-Dihydroxytryptamine; Acoustic Stimulation; Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Carrier Proteins; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Radiation; Drug Interactions; Excitatory Amino Acid Antagonists; Hyperkinesis; Immunohistochemistry; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microinjections; Motor Activity; Nerve Tissue Proteins; Neural Inhibition; Phencyclidine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Reaction Time; Reflex, Startle; Schizophrenia; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Time Factors | 2003 |
Anxiolytic-like effects of median raphe nucleus lesion in the elevated T-maze.
Topics: 5,7-Dihydroxytryptamine; Analysis of Variance; Animals; Anxiety; Avoidance Learning; Brain Diseases; Disease Models, Animal; Electrolysis; Escape Reaction; Male; Maze Learning; Raphe Nuclei; Rats; Reaction Time | 2004 |
Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
Topics: 5,7-Dihydroxytryptamine; Animals; Axons; Behavior, Animal; Blotting, Northern; Blotting, Southern; Brain; Cell Count; Cells, Cultured; Cloning, Molecular; Cornified Envelope Proline-Rich Proteins; Desipramine; Disease Models, Animal; Evoked Potentials, Motor; Female; Ganglia, Spinal; Glial Fibrillary Acidic Protein; Glucose; GPI-Linked Proteins; Growth Cones; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Myelin Proteins; Myelin Sheath; Myelin-Associated Glycoprotein; Nerve Regeneration; Neurons; Nogo Proteins; Nogo Receptor 1; Phospholipid Ethers; Proteins; Pyramidal Tracts; Receptors, Cell Surface; Recovery of Function; Serotonin; Serotonin Agents; Spinal Cord; Spinal Cord Injuries; Time Factors | 2004 |
Brainstem seizure severity regulates forebrain seizure expression in the audiogenic kindling model.
Topics: 5,7-Dihydroxytryptamine; Acoustic Stimulation; Animals; Brain; Brain Chemistry; Brain Stem; Disease Models, Animal; Electric Stimulation; Electrodes, Implanted; Electroencephalography; Epilepsy, Reflex; Injections, Intraventricular; Kindling, Neurologic; Norepinephrine; Phenytoin; Prosencephalon; Rats; Seizures; Serotonin; Serotonin Agents; Severity of Illness Index; Superior Colliculi | 2005 |
Ventilatory response to hypercapnia and hypoxia after extensive lesion of medullary serotonergic neurons in newborn conscious piglets.
Topics: 5,7-Dihydroxytryptamine; Animals; Animals, Newborn; Carbon Dioxide; Disease Models, Animal; Female; Humans; Hypercapnia; Hypoxia; Infant, Newborn; Male; Medulla Oblongata; Neurons; Pulmonary Ventilation; Raphe Nuclei; Respiration; Respiratory Mechanics; Serotonin; Sex Factors; Sleep Stages; Sudden Infant Death; Swine | 2006 |
Proposed animal model of attention deficit hyperactivity disorder.
Topics: 5,7-Dihydroxytryptamine; Animals; Animals, Newborn; Attention Deficit Disorder with Hyperactivity; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Female; Male; Motor Activity; Movement; Nerve Fibers; Oxidopamine; Random Allocation; Rats; Serotonin; Stereotyped Behavior | 1994 |
p,p'-DDT myoclonic/epileptic model: serotonin receptor binding and behavioral studies in the rat.
Topics: 5,7-Dihydroxytryptamine; Animals; Behavior, Animal; DDT; Disease Models, Animal; Epilepsies, Myoclonic; Male; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Seizures | 1994 |
Altered respiratory motor drive after spinal cord injury: supraspinal and bilateral effects of a unilateral lesion.
Topics: 5,7-Dihydroxytryptamine; Adrenergic Uptake Inhibitors; Animals; Axotomy; Brain Stem; Disease Models, Animal; Female; Functional Laterality; Hypercapnia; Hypoglossal Nerve; Hypoxia; Injections, Intraventricular; Motor Neurons; Neuronal Plasticity; Phrenic Nerve; Rats; Respiration; Respiration, Artificial; Respiratory System; Serotonin Agents; Specific Pathogen-Free Organisms; Spinal Cord; Spinal Cord Injuries; Vagotomy | 2001 |